Gene Query: RHOC

Dataset Description Geneva Score
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 77.51
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 48.14
Genome wide expression change in LCC2 and MCF-7 cells 47.44
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 45.14
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 42.02
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 36.55
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 35.91
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 34.79
Mechanistic Model-Guided Study of Embryonic Morphogenesis 34.52
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 33.79
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 32.65
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 32.36
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 32.36
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 30.57
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 30.57
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 30.02
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 29.05
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 28.99
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 28.68
Tracking of dCas9-methyltransferase footprints 28.59
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 28.46
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 27.94
Proliferation-correlated expression 27.66
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 27.1
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 26.98
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 26.26
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 26.07
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 25.67
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 25.42
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 25.37
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 24.61
DJ-1 is dispensable for human stem cell homeostasis 24.59
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 24.51
RNA sequencing analysis of human embryonic stem cells and axial progenitors 24.45
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 23.91
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 23.5
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 23.5
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 23.01
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 22.86
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 22.54
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 22.54
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 22.49
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 22.37
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 22.37
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 22.14
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 22.1
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 21.9
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 21.88
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 21.6
RNA sequencing with KSHV infection and enrichment for circular RNAs 21.5
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 21.49
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 21.25
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 21.25
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 20.89
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 20.86
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 20.86
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 20.84
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 20.76
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 20.76
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 20.76
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 20.63
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 20.63
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 20.29
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 20.04
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 20.04
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 19.93
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 19.89
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 19.74
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 19.59
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 19.47
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 19.43
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 19.43
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 19.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 19.15
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 19.1
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 19.09
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 19.05
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 19.05
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 18.48
Gene expression profiling of human and murine in vitro muscle differentiation 18.38
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 18.31
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 18.25
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 18.18
RNA-seq analyisis of PUM2 knockout cells 18.04
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 17.94
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 17.94
Modeling Familial Cancer with iPSC Approaches 17.88
BI Human Reference Epigenome Mapping Project 17.86
NRDE2 negatively regulates nuclear exosome functions 17.82
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 17.81
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 17.67
Controlling for gene expression changes in transcription factor protein networks. 17.67
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 17.48
Gene Expression Profiling of SPOP Knocked Down Cell 17.47
Accurate annotation of human protein-coding small open reading frames 17.47
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 17.28
Genome-wide chromatin analysis of Ewing sarcoma 17.28
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 17.18
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 17.17
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 17.12
Differentially expressed vascular development genes for iPSC-ECs from CDI 17.05
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 16.98
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 16.98
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 16.92
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 16.9
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 16.9
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 16.75
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 16.75
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 16.74
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 16.7
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 16.52
Human Treg IL-12 stimulation 16.43
Stem and effector CD8 T-cells from human cancers 16.31
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 16.29
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 16.25
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 16.25
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 16.18
Global transcriptome analysis of HAP1 cells 16.17
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 16.12
The landscape of alternative splicing in aggressive prostate cancers 16.09
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 16.09
DIGIT regulates endoderm differentiation of human embryonic stem cells 15.98
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 15.72
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 15.71
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 15.69
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 15.51
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 15.48
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 15.42
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 15.38
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 15.36
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 15.34
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 15.33
Hepatitis C virus functionally sequesters miR-122 15.28
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 15.28
Gene expression changes associated with resistance to tagraxofusp (SL-401) 15.22
Cerebellar differentiation in Ataxia-Telangiectasia 15.21
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 14.99
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 14.99
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 14.94
Single-nucleotide-resolution mapping of HBV promoters using CAGE 14.79
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 14.77
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 14.74
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 14.64
Biological effect of chronic mistranslation in mammalian cells 14.58
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 14.51
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 14.49
The human blood-nerve barrier transcriptome 14.47
Identification of Atrial Fibrillation associated genes and functional non-coding variants 14.42
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 14.37
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 14.35
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 14.35
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 14.33
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 14.33
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 14.32
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 13.91
Targeting MTHFD2 in Acute Myeloid Leukemia 13.9
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 13.86
Epigenomic landscape during organ formation in human early embryos 13.84
PNET animal model: new insights (II) 13.78
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.74
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 13.71
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 13.6
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 13.6
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 13.6
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 13.59
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 13.57
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 13.55
Gene expression analysis of the impact of TDP-43 knockout in human cells. 13.54
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 13.54
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 13.46
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 13.46
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 13.35
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 13.35
LncRNA expression profiling of ischemic stroke patients 13.3
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 13.18
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 13.07
RNA-seq melanoma 13.04
Differential gene expression profiles in imatinib-resistant cell lines 13.01
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 12.95
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 12.89
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 12.84
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 12.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 12.74
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 12.72
Global gene expression profile of dasatinib-resistant RCH-ACV cells 12.71
Gene expression changes upon drug withdrawal (Mel888 cell line) 12.65
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 12.64
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 12.61
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 12.57
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 12.48
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 12.48
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 12.47
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 12.45
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 12.45
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 12.43
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 12.43
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 12.31
Widespread regulated alternative splicing of single codons accelerates proteome evolution 12.28
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 12.27
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.26
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 12.24
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 12.2
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 12.17
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 12.14
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 12.14
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 12.13
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.13
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 12.07
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.04
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 11.97
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 11.95
Gene expression analysis of human liver progenitor-like cells in culture 11.65
Gene expression signatures of innate lymphoid cells from human blood 11.65
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 11.62
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 11.6
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 11.6
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.59
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 11.56
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 11.56
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 11.54
Genome-wide analysis of the Integrator complex 11.46
Genome-wide analysis of the Integrator complex (HTS) 11.46
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 11.45
miR-93 Targets in Human Endothelial Cells 11.41
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 11.4
Mitochondrial dsRNA triggers antiviral signalling in humans 11.27
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 11.27
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 11.18
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 11.17
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 11.17
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 11.1
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 11.1
RNA-seq analysis of the human fetal kidney. 11.1
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 11.07
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 11.06
Ribosomal footprinting of MDA-Parental and MDA-LM2 11.06
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 11.02
Global analysis of enhancer targets: Mosaic-seq 10.99
T47D RNA-seq and ChrRNA-seq data 10.98
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 10.98
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 10.97
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 10.96
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 10.95
Electronic cigarettes 10.92
iPSC-Derived Cholangiocytes 10.91
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 10.85
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 10.83
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 10.82
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.77
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 10.76
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 10.74
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 10.72
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 10.71
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 10.7
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 10.69
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 10.68
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 10.65
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 10.59
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 10.57
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.56
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 10.5
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 10.5
Transcriptomes of oxLDL exposed trained monocytes 10.48
oxLDL exposed trained monocytes 10.48
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 10.42
HEK293 TFAM Knockout Expression Study 10.42
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 10.38
RNA-seq analysis of RALD iPSCs after in vitro differentiation 10.38
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 10.37
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 10.37
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 10.34
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 10.29
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 10.27
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 10.27
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 10.27
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 10.24
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 10.22
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 10.22
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 10.16
scRNASeq analysis of cycling cardiomyocytes 10.15
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.03
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.03
Transcriptional landscape changes during human embryonic stem cell derivation 10.02
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 9.98
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 9.96
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 9.96
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 9.96
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 9.94
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 9.89
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 9.88
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 9.84
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 9.82
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 9.79
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.79
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 9.72
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.69
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 9.58
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 9.57
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 9.56
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 9.51
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 9.51
Activity-dependent transcriptional changes in human neurons 9.46
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 9.46
Non-coding regions are the main source of tumor-specific antigens 9.4
Non-coding regions are the main source of tumor-specific antigens [human] 9.4
Transcription elongation regulates genome 3D structure 9.4
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 9.37
Co-regulation of splicing by Rbfox1 and hnRNP M 9.32
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.32
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 9.24
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.22
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 9.2
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 9.11
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 9.1
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 9.06
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 9.05
Exploring the RNA landscape of endothelial exosomes 9.05
WRN knockout effects upon gene expression in SW48 and OVK18 9.03
The DPYSL2 gene connects mTOR and schizophrenia 9.0
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.88
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 8.84
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 8.77
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 8.75
RNA-Sequencing of HepG2 cells treated with TGFBeta 8.66
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 8.66
Anti-inflammatory effect of indoleacrylic acid (IA) 8.64
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 8.64
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 8.54
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 8.54
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 8.52
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 8.46
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 8.43
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.39
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.39
PRDM1 inhibits proliferation of human colon cancer organoids 8.34
mRNA expression profile of Lymphocytes by high-throuput sequencing 8.2
Downregulation of DDX5/DDX17 and REST 8.18
Gene expression profiling of KSHV-infected periodontal ligament cells 8.07
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 7.97
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.86
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 7.77
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 7.76
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 7.76
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 7.56
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 7.46
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 7.35
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.34
miR941 overexpression experiment 7.33
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 7.3
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 7.3
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 7.24
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 7.16
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 7.12
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.1
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 7.09
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 6.93
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 6.89
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 6.71
Differential responses of human fetal brain neural stem cells to Zika virus infection 6.7
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.64
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.6
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 6.54
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 6.54
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 6.54
Alagille_Nodder 6.47
RNA Seq of Alagille liver biopsies 6.47
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 6.46
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 6.43
Transcriptome analyses of human pancreatic islets and pseudoislets 6.41
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 6.41
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.3
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 6.28
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 6.22
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 6.2
EWS-Fli and LNC regulated genes in comparison to GFP samples 6.19
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.16
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 6.11
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 6.06
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 6.05
Hepatocyte maturation 6.05
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 6.01
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.94
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.83
circNFIB suppresses lymphatic metastasis of pancreatic cancer 5.8
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.75
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.74
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 5.67
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 5.63
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.56
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 5.5
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.38
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.38
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.27
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 5.24
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.14
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.14
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.83
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.81
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.72
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.66
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 4.57
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 4.51
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.49
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.49
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 4.45
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 4.33
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 4.32
Transcriptome of human ILC2s; primary vs IL-1b-primed 4.24
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.22
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.22
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 4.21
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 4.16
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.11
Identification of renal resident macrophages across species [C1] 4.02
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.01
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 3.92
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 3.92
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.91
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.91
RNA seq_PDX2_SHP099 3.91
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.83
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.77
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.75
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.72
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 3.52
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.41
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.28
Gene profiling of human adult and pediatric liver cancer cells 3.27
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 3.19
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.04
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.03
Expression profiling of MCF-7 cells with treatment of TCDD 3.03
Single-cell analysis of human kidney organoids 3.03
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 3.03
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.99
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 2.83
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.82
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.76
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.72
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.65
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 2.64
Unique features and clinical importance of acute alloreactive immune responses 2.61
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.59
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.57
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.51
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.47
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.46
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 2.41
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 2.41
Discovering human diabetes-risk gene function with genetics and physiological assays 2.38
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.34
Human ovarian granulosa cell transcriptome 2.28
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 2.23
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.22
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.2
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.12
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.01
Identification of long noncoding RNAs regulated by p53 1.92
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.86
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.79
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.75
JAK dependent survival of ALK- ALCL 1.62
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.47
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.44
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.44
Leucegene: ALL sequencing 1.44
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.43
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.43
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.26
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.22
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.2
Positively selected enhancer elements endow tumor cells with metastatic competence 1.2
Polarized B -cell functions 1.11
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.1
Human islets of varying quality: the good, the (not so) bad and the ugly 1.08
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.0
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.84
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.77
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.74
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.66
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.66
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.59
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.59
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.58
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.56
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.55
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.55
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.55
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.51
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.48
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.38
Characterization of human ILC2 subsets 0.31
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 0.29
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.27
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.18
siRNA-mediated knockdown 0.15
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.1
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation